Bryn Pharma, a privately held pharmaceutical company focused on creating a new treatment for anaphylaxis – a life-threatening allergic reaction – not only has a new CEO and COO but also $15 million in cash as the company seeks FDA approval for its unique nasal spray.
Source: WRAL News
Fighting anaphylaxis without needles: Raleigh pharma startup raises $15M
More from MarshallbergMore posts in Marshallberg »
- Outer Banks flooding and overwash closes NC 12, ferry on Ocracoke Island
- Dog that escaped Alaska Airlines flight at RDU now reunited with owner
- State to give back control of child welfare services of Nash Social Services, documents show
- 19-year-old killed in Granville crash witnessed by school bus driver, students
- Explosive 'resembling a Molotov Cocktail' thrown at Fuquay-Varina home, duo charged with having 'weapon of mass destruction'
Be First to Comment